Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
87.5M
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
18M
-
Shares change
-
-477K
-
Total reported value, excl. options
-
$275M
-
Value change
-
-$7.19M
-
Number of buys
-
37
-
Number of sells
-
-27
-
Price
-
$15.30
Significant Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q4 2017
77 filings reported holding KURA - Kura Oncology, Inc. - Common Stock as of Q4 2017.
Kura Oncology, Inc. - Common Stock (KURA) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18M shares
of 87.5M outstanding shares and own 20.58% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (3.77M shares), GREAT POINT PARTNERS LLC (2.2M shares), FMR LLC (2.08M shares), Partner Fund Management, L.P. (1.75M shares), BVF INC/IL (1.35M shares), Vanguard Group Inc (1.09M shares), Boxer Capital, LLC (845K shares), Candriam Luxembourg S.C.A. (515K shares), NEXTHERA CAPITAL LP (446K shares), and Sio Capital Management, LLC (392K shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.